Latest Breaking News On - Board of directors fine foods pharmaceuticals - Page 1 : comparemela.com

The Board of Directors of Fine Foods & Pharmaceuticals N T M S p A approved the Group s Interim Financial Report as of 31 March 2024: EBITDA Margin reached 13 5%, exceeding historical levels

The Board of Directors of Fine Foods & Pharmaceuticals N T M S p A approved the Group s Interim Financial Report as of 31 March 2024: EBITDA Margin reached 13 5%, exceeding historical levels
marketscreener.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from marketscreener.com Daily Mail and Mail on Sunday newspapers.

Verdellino bergamoGiorgio ferrarisPharmaceuticals business unitFine foods pharmaceuticalsGroup net financial positionBoard of directors fine foods pharmaceuticalsInternational accounting standards boardContract development manufacturing organisationGroup interim financialFine foodsInterim financial reportNet financial positionContract developmentManufacturing organisationConsolidated revenueBusiness unit